Roth MKM keeps a Buy rating and $220 price target on Alphabet (GOOGL) after the company’s $32B Wiz acquisition – the largest in Google’s ...
Roth MKM analyst Rohit Kulkarni maintained a Buy rating on Alphabet Class A (GOOGL – Research Report) today and set a price target of $220.00.
Fintel reports that on March 17, 2025, Roth MKM initiated coverage of EZCORP (NasdaqGS:EZPW) with a Buy recommendation.
Research analysts at Roth Mkm started coverage on shares of EZCORP (NASDAQ:EZPW – Get Free Report) in a report released on Monday, Marketbeat.com reports. The brokerage set a “buy” rating and a $16.00 ...
Gogo (NASDAQ:GOGO – Free Report) had its price target reduced by Roth Mkm from $15.50 to $13.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the ...
Roth MKM lowered the firm’s price target on Tilly’s (TLYS) to $2.50 from $5 and keeps a Neutral rating on the shares. The ...
Roth MKM says Semtech (SMTC) reported Q4 beat and Q1 guidance raise driven by data center strength as well as a recovery in ...
One firm that has worked closely with technology stocks and engaged in investment rounds for technology startups is the investment bank Roth MKM. The firm claims to have “raised over $60 billion ...
Credo Technology Group (NASDAQ:CRDO) issued its third-quarter earnings report on Tuesday. It reported quarterly earnings of ...
In a report released today, Gerry Sweeney from Roth MKM maintained a Buy rating on Allient (ALNT – Research Report), with a price target of $28.00. The company’s shares closed ...
Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results